Precision Genomic Testing Market to Grow at 11.4% CAGR, Reaching $23.11 Billion by 2029

Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.

Precision Genomic Testing Market Outlook: How is the Market Expected to Grow by 2025?
In recent times, the precision genomic testing market has seen a quick escalation in its magnitude. The market which stood at $13.44 billion in 2024 is set to elevate to $15.00 billion in 2025, indicating a compound annual growth rate (CAGR) of 11.6%. This leap in the historical phase is associated with several factors such as the increased availability of direct-to-consumer genetic examinations, a surge in alliances between pharmaceutical and diagnostic entities, heightened attention towards preventive healthcare, increased uptake of companion diagnostics, and enhanced cognizance towards early ailment identification.

Precision Genomic Testing Market Forecast: What Size Will It Reach By 2029?
The market for precision genomic testing is anticipated to experience accelerated expansion over the coming few years, with expectations of reaching a value of $23.11 billion in 2029, representing a compound annual growth rate (CAGR) of 11.4%. There are several factors contributing to this predicted growth in the forecasted period, including an upswing in demand for precision oncology solutions, renewing emphasis on diagnosis of rare diseases, increased financial commitment in population genomics projects, the growing tendency towards multi-omics methods, and an expanding need for non-invasive prenatal screening. Foreseen trends within the prognosis period incorporate progress in next-generation sequence technologies, creative strides in liquid biopsy techniques, the application of artificial intelligence in genomic investigations, progress in interpreting multi-omics data, along with advancements in direct-to-consumer genetic testing models.

Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/precision-genomic-testing-global-market-report

Which Key Market Drivers Will Shape Precision Genomic Testing Industry Trends in 2025-2029?
The increase in genetic disorders is anticipated to boost the expansion of the precision genomic testing market. Genetic disorders are medical conditions caused by deviations in a person's DNA, like variations in a solitary gene, numerous genes, or alterations in the arrangement or quantity of chromosomes. This surge in genetic disorders is chiefly attributed to escalating maternal age, given that older mothers are at a more significant risk of transmitting chromosomal abnormalities such as down syndrome to their offspring. Precision genomic testing supports the premature detection and precise diagnosis of genetic disorders by pinpointing certain genetic variations, permitting specific interventions and tailored treatment plans. For example, in May 2025, the UK-based registered charity Gene People revealed that there's an estimation that genetic illnesses impact 1 in 25 kids, influencing over 2.4 million children and grown-ups in the UK. Furthermore, close to 30,000 newborns and kids in the UK receive a genetic condition diagnosis each year. For these reasons, the surge in genetic disorders is the driving force behind the expansion of the precision genomic testing market.

Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25883&type=smp

What Are the High-Growth Segments in the Precision Genomic Testing Market?
The precision genomic testing market covered in this report is segmented -

1) By Product And Service: Consumables, Equipment, Services
2) By Technology: Next-Generation Sequencing, Polymerase Chain Reaction, Microarray Technology, Sanger Sequencing, Clustered Regularly Interspaced Short Palindromic Repeats Or Clustered Regularly Interspaced Short Palindromic Repeats-Associated Systems, Other Technologies
3) By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Reproductive Health, Rare Diseases, Other Applications
4) By End-Users: Hospitals And Clinics, Diagnostic Laboratories, Research And Academic Institutes, Other End-Users

Subsegments:
1) By Consumables: Reagents And Kits, Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits, Library Preparation Kits, Sequencing Reagents, Polymerase Chain Reaction Assay Kits, Buffers And Enzymes
2) By Equipment: Next-Generation Sequencing Systems, Polymerase Chain Reaction Machines, Microarray Instruments, Deoxyribonucleic Acid Analyzers, Bioinformatics Workstations, Laboratory Automation Systems
3) By Services: Genomic Data Analysis Services, Laboratory Testing Services, Genetic Counseling Services, Clinical Interpretation Services, Contract Research Services, Custom Assay Development Services

Which Global Trends Are Driving Precision Genomic Testing Market Expansion?
Prominent firms in the precision genomic testing market are directing their efforts towards creating groundbreaking solutions, including ultra-sensitive circulating tumor deoxyribonucleic acid assays. These advanced tests help in the earlier and more accurate identification of cancer by detecting minuscule fragments of tumor-derived deoxyribonucleic acid in the bloodstream, pinpointing the presence of genetic mutations linked to cancer with enhanced precision. To illustrate, Natera Inc., a clinical genetic testing company from the United States, unveiled the ultra-sensitive Signatera genome molecular residual disease test in April 2025. This test applies whole genome sequencing to both a patient's tumor and matched normal deoxyribonucleic acid, facilitating the creation of a tailored assay. As a result, circulating tumor deoxyribonucleic acid can be identified even at incredibly low concentrations of 1 part per million. The high sensitivity of this test promotes the earlier detection of cancer recurrence and improves accuracy, ultimately leveraging treatment planning and patient management for different types of cancer.

Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25883&type=smp

Who Are the Fastest-Growing Companies in the Precision Genomic Testing Industry?
Major companies operating in the precision genomic testing market are Roche Diagnostics International AG, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Exact Sciences Corporation, Natera Inc., Myriad Genetics Inc., GenScript Biotech Corporation, Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., Ambry Genetics Corporation, Color Health Inc., Pacific Biosciences, Eurofins Genomics LLC, Precision Genetics.

What Is the Regional Outlook for the Precision Genomic Testing Market by 2029?
North America was the largest region in the precision genomic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision genomic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.